Literature DB >> 11443223

A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity.

M Mergen1, H Mergen, M Ozata, R Oner, C Oner.   

Abstract

Mutations in the melanocortin 4 receptor gene (MC4R) are the most common cause of monogenic human obesity. As part of our ongoing project entitled 'Turkish Obesity Genome Study' we determined the nucleotide sequence of the entire coding region of the MC4R gene in 40 morbidly obese subjects from independent families. Here we report a novel heterozygous mutation (N274S) in an adult female obese individual (age: 52 yrs, BMI 41.7 kg/m(2), height 158 cm, weight: 104 Kg). The sister of the index case (age: 55 yrs, height: 160 cm, weight: 110 Kg, BMI: 43 kg/m(2)) also carries the same mutation. Although both sisters were morbidly obese and hypertensive the index case had normal plasma insulin and fasting blood glucose levels whereas her sister had type 2 diabetes mellitus. No abnormalities of the reproductive function were present. Despite marked hyperphagia in childhood both sisters had a history of relatively diminished intensity of appetite after the age of 20. Of notice, index case was diagnosed to have cyclothymia whereas her sister was being treated for bipolar affective disorder. Detailed clinical evaluation revealed normal bone mineral density and serum calcium parameters as well as intact thyroid axis and hypothalamus-pituitary-adrenal axis in both patients. The human MC4-R deficient phenotype resembles the murine deficient state with regard to preserved reproductive function although hyperphagia, increased linear growth and absence of diabetes in mice are not observed in humans. Affected individuals have hyperphagia in childhood, which looses intensity later in life, and they also present with normal height and diabetes mellitus. Accumulating evidence indicate that melanocortin endocrine system or defective melanocortin signaling has inherently different characteristics in mice and humans resembling the variation observed with regard to leptin deficiency in both species.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443223     DOI: 10.1210/jcem.86.7.7809

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  Mouse models of the metabolic syndrome.

Authors:  Arion J Kennedy; Kate L J Ellacott; Victoria L King; Alyssa H Hasty
Journal:  Dis Model Mech       Date:  2010 Mar-Apr       Impact factor: 5.758

2.  Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks.

Authors:  Irena Aldhoon Hainerová; Hana Zamrazilová; Dana Sedláčková; Vojtěch Hainer
Journal:  Obes Facts       Date:  2011-07-28       Impact factor: 3.942

3.  Evaluation of MC4R [rs17782313, rs17700633], AGRP [rs3412352] and POMC [rs1042571] Polymorphisms with Obesity in Northern India.

Authors:  Apurva Srivastava; Balraj Mittal; Jai Prakash; Varun Shanker Narain; S M Natu; Neena Srivastava
Journal:  Oman Med J       Date:  2014-03

4.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

5.  The common obesity variant near MC4R gene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women.

Authors:  Lu Qi; Peter Kraft; David J Hunter; Frank B Hu
Journal:  Hum Mol Genet       Date:  2008-08-12       Impact factor: 6.150

6.  Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study.

Authors:  Melissa A Calton; Baran A Ersoy; Sumei Zhang; John P Kane; Mary J Malloy; Clive R Pullinger; Yana Bromberg; Len A Pennacchio; Robert Dent; Ruth McPherson; Nadav Ahituv; Christian Vaisse
Journal:  Hum Mol Genet       Date:  2008-12-17       Impact factor: 6.150

7.  Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse.

Authors:  Carrie Haskell-Luevano; Jay W Schaub; Amy Andreasen; Kim R Haskell; Marcus C Moore; Lorraine M Koerper; Francois Rouzaud; Henry V Baker; William J Millard; Glenn Walter; S A Litherland; Zhimin Xiang
Journal:  FASEB J       Date:  2008-10-29       Impact factor: 5.191

8.  Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides.

Authors:  Yaniv Linde; Oded Ovadia; Eli Safrai; Zhimin Xiang; Federico P Portillo; Deborah E Shalev; Carrie Haskell-Luevano; Amnon Hoffman; Chaim Gilon
Journal:  Biopolymers       Date:  2008       Impact factor: 2.505

9.  The melanocortin system and insulin resistance in humans: insights from a patient with complete POMC deficiency and type 1 diabetes mellitus.

Authors:  I R Aslan; S A Ranadive; I Valle; S Kollipara; J A Noble; C Vaisse
Journal:  Int J Obes (Lond)       Date:  2013-05-07       Impact factor: 5.095

Review 10.  Approach to assessing determinants of glucose homeostasis in the conscious mouse.

Authors:  Curtis C Hughey; David H Wasserman; Robert S Lee-Young; Louise Lantier
Journal:  Mamm Genome       Date:  2014-07-30       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.